Literature DB >> 21914149

Repeat intravitreal triamcinolone acetonide injections in uveitic macular oedema.

Ahmed Sallam, Simon R J Taylor, Zohar Habot-Wilner, Mostafa Elgohary, Helen H Do, Peter McCluskey, Sue Lightman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21914149     DOI： 10.1111/j.1755-3768.2011.02247.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  15 in total

1.  [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014].

Authors:  A Heiligenhaus; B Bertram; C Heinz; L Krause; U Pleyer; J Roider; S Sauer; S Thurau
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

2.  Intraocular pressure elevation after intravitreal triamcinolone acetonide injection: a Meta-analysis.

Authors:  Cansu Yuksel-Elgin; Ceyhun Elgin
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

3.  Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy.

Authors:  Valerie Touitou; Mary A Johnson; Yan Guo; Neil R Miller; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-11       Impact factor: 4.799

4.  Periocular corticosteroid injections in uveitis: effects and complications.

Authors:  H Nida Sen; Susan Vitale; Sapna S Gangaputra; Robert B Nussenblatt; Teresa L Liesegang; Grace A Levy-Clarke; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; John H Kempen
Journal:  Ophthalmology       Date:  2014-07-11       Impact factor: 12.079

5.  Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.

Authors:  Jennifer E Thorne; Elizabeth A Sugar; Janet T Holbrook; Alyce E Burke; Michael M Altaweel; Albert T Vitale; Nisha R Acharya; John H Kempen; Douglas A Jabs
Journal:  Ophthalmology       Date:  2018-09-27       Impact factor: 14.277

6.  Local therapies for inflammatory eye disease in translation: past, present and future.

Authors:  Shenzhen Tempest-Roe; Lavnish Joshi; Andrew D Dick; Simon R J Taylor
Journal:  BMC Ophthalmol       Date:  2013-08-06       Impact factor: 2.209

Review 7.  Management of noninfectious posterior uveitis with intravitreal drug therapy.

Authors:  Hui Yi Tan; Aniruddha Agarwal; Cecilia S Lee; Jay Chhablani; Vishali Gupta; Manoj Khatri; Jayabalan Nirmal; Carlos Pavesio; Rupesh Agrawal
Journal:  Clin Ophthalmol       Date:  2016-10-13

8.  KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress.

Authors:  Masayuki Hata; Hanako O Ikeda; Chinami Kikkawa; Sachiko Iwai; Yuki Muraoka; Tomoko Hasegawa; Akira Kakizuka; Nagahisa Yoshimura
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

Review 9.  Birdshot uveitis: current and emerging treatment options.

Authors:  Victor Menezo; Simon Rj Taylor
Journal:  Clin Ophthalmol       Date:  2013-12-18

10.  Twelve-Month Results of a Single or Multiple Dexamethasone Intravitreal Implant for Macular Edema following Uncomplicated Phacoemulsification.

Authors:  Solmaz Abdolrahimzadeh; Vito Fenicia; Maurizio Maurizi Enrici; Pasquale Plateroti; Dora Cianfrone; Santi Maria Recupero
Journal:  Biomed Res Int       Date:  2015-10-05       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.